WHO ICTRP trial
EEG-Based Efficacy Evaluation of Lecanemab Treatment in Alzheimer's Disease
ChiCTR2500106454 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500106454 |
|---|---|
| Public title | EEG-Based Efficacy Evaluation of Lecanemab Treatment in Alzheimer's Disease |
| Scientific title | EEG-Based Efficacy Evaluation of Lecanemab Treatment in Alzheimer's Disease |
| Primary sponsor | Shenzhen people's hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Alzheimer's diasease |
| Interventions | Observation Group:None |
| Registration date | Jul 24, 2025 |
| Target size | Observation Group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: